Background¶
Purpose¶
The purpose of this site is to provide NHS Clinical Scientists, Clinicians and Bioinformaticians a step-by-step guide to the Genomics England Cancer Decision Support Software (Cancer-DSS).
Scope¶
This site covers how users of Cancer DSS can:
- Open cancer cases ready for NHS GLH review, and track case status.
- Review findings from the analysis of cancer WGS cases.
- Assign classification to somatic and germline variants identified in the patient.
- Export selected variants for reporting or clinical review.
Target Audience¶
Genomic Laboratory Hub (GLH) staff handling the interpretation of Cancer whole genome sequencing (WGS) data using the Genomics England Interpretation Platform.
Other Third Party Audience
The external audience for this document may include medical device regulators and associated agencies in the pursuit of medical device regulatory and standards certification including:
UK Competent Authority: (CAs) the Medicines and Healthcare Products Regulatory Agency (MHRA); Notified Bodies (NBs) such as BSI Group; NHS Digital; the NHS IT regulator in England and Wales. This document may also be requested by existing and prospective Genomics England customers as part of their procurement process. All external distribution of the must be approved by a member of the Quality Improvements and Regulatory Affairs team prior to circulation.
Additional Resources¶
Interpretation Platform Documentation
Feedback¶
If you have any feedback on Cancer DSS please raise a ticket via the Genomics England Service Desk.